Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6034239 | TAKEDA PHARMS USA | Tricyclic compounds, their production and use |
Jul, 2019
(4 years ago) | |
US10098866 | TAKEDA PHARMS USA | Pharmaceutical preparation containing copolyvidone |
Nov, 2021
(2 years ago) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
M(M-82) | Oct 20, 2011 |
Market Authorisation Date: 22 July, 2005
Treatment: Method of treating insomnia characterized by difficulty with sleep onset; Method of treating a biological rhythm disorder, such as insomnia
Dosage: TABLET;ORAL